5-[2-(3-Methoxy-phenoxy)-ethyl]-[1,3,4]-thiadiazol-2-ylamine
|
- $378 - $777.32
- Product name: 5-[2-(3-Methoxy-phenoxy)-ethyl]-[1,3,4]-thiadiazol-2-ylamine
- CAS: 878656-33-8
- MF: C11H13N3O2S
- MW: 251.3
- EINECS:
- MDL Number:MFCD07391722
- Synonyms:ASINEX-REAG BAS 07340757;TIMTEC-BB SBB011955;5-(2-(3-Methoxyphenoxy)ethyl)-1,3,4-thiadiazol-2-amine;1,3,4-Thiadiazol-2-amine, 5-[2-(3-methoxyphenoxy)ethyl]-;5-[2-(3-Methoxy-phenoxy)-ethyl]-[1,3,4]-thiadiazol-2-ylamine
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500MG
- 1.00g
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0134144
- Product description5-[2-(3-METHOXY-PHENOXY)-ETHYL]-[1,3,4]THIADIAZOL-2-YLAMINE 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018851
- Product description5-[2-(3-Methoxy-phenoxy)-ethyl]-[1,3,4]-thiadiazol-2-ylamine
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018851
- Product description5-[2-(3-Methoxy-phenoxy)-ethyl]-[1,3,4]-thiadiazol-2-ylamine
- Packaging1.00g
- Price$378
- Updated2026-05-18
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0134144 | 5-[2-(3-METHOXY-PHENOXY)-ETHYL]-[1,3,4]THIADIAZOL-2-YLAMINE 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
| Matrix Scientific | 018851 | 5-[2-(3-Methoxy-phenoxy)-ethyl]-[1,3,4]-thiadiazol-2-ylamine | 1g | $378 | 2021-12-16 | Buy |
| Matrix Scientific | 018851 | 5-[2-(3-Methoxy-phenoxy)-ethyl]-[1,3,4]-thiadiazol-2-ylamine | 1.00g | $378 | 2026-05-18 | Buy |
Properties
Boiling point :457.7±51.0 °C(Predicted)
Density :1.303±0.06 g/cm3(Predicted)
pka :3.33±0.10(Predicted)
Density :1.303±0.06 g/cm3(Predicted)
pka :3.33±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




